Development of smart optical agents for disease theranostics

For the past decades, tremendous progress has been made in the field of biophotonics with applications in both biomedical research and clinical practice. With the merits of high sensitivity and specificity in real-time biological investigations and increased versatility and multimodality adaptive to...

Full description

Saved in:
Bibliographic Details
Main Author: Zeng, Ziling
Other Authors: Pu Kanyi
Format: Thesis-Doctor of Philosophy
Language:English
Published: Nanyang Technological University 2024
Subjects:
Online Access:https://hdl.handle.net/10356/173441
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Nanyang Technological University
Language: English
id sg-ntu-dr.10356-173441
record_format dspace
spelling sg-ntu-dr.10356-1734412024-03-07T08:52:05Z Development of smart optical agents for disease theranostics Zeng, Ziling Pu Kanyi Interdisciplinary Graduate School (IGS) kypu@ntu.edu.sg Engineering For the past decades, tremendous progress has been made in the field of biophotonics with applications in both biomedical research and clinical practice. With the merits of high sensitivity and specificity in real-time biological investigations and increased versatility and multimodality adaptive to diverse research and clinical needs, biophotonics as a powerful and non-invasive tool holds significant potential in disease treatment and diagnostics. Compared to inorganic optical agents, organic optical agents possess superiorities of high biocompatibility and biosafety, structurally tunable properties, and relatively low cost, rendering them attractive candidates for two major biomedical applications of biophotonics: 1) light-activated therapy; 2) optical imaging and diagnosis. Despite the fact that a diverse array of organic optical agents has been exploited in preclinical studies, there is still ample room for improvement and expanded clinical applications, such as lack in a precisely controllable manner, noninvasive, dynamic diagnosis of disease, or monitoring of disease progression. Therefore, our group has dedicated great efforts to overcoming these challenges, improving the performance of activatable optical agents, and expanding their use in various disease models and practical scenarios. This thesis is built with a structure of the following: a comprehensive review emphasizing past studies and current advances in biophotonics for disease treatment and diagnosis. Next, my studies that focused on improving optical agents from the aspects of precise control and extended clinical applications are presented. Specifically, to achieve the precise control of therapeutics, Chapter 3 investigates activatable organic semiconducting polymer nanoparticles (SPNs) for combination photodynamic immunotherapy, in which both photodynamic and immunotherapeutic activities can be controlled by photoirradiation. Based on Chapter 3, Chapter 4 further explores the SPNs as sonosensitizers for activatable sonoimmunotherpy, which overcomes the shallow tissue penetration of light, an inherent limitation of conventional phototherapy. To broaden the clinical applications and enhance the translational potential of activatable optical agents, Chapter 5 investigates a proof-of-concept approach to develop novel inhalable activatable probes, which enable both in vivo NIRF imaging and optical urinalysis allowing non-invasive and real-time detection of SARS-CoV-2. Inspired by this concept, Chapter 6 investigated the use of inhalable probes in longitudinal monitoring of disease progression and treatment outcomes. Finally, considering the rapid progression and great potential of smart optical agents, future perspectives from the aspects of optical agent development and clinical translation are proposed. Doctor of Philosophy 2024-02-05T05:10:32Z 2024-02-05T05:10:32Z 2023 Thesis-Doctor of Philosophy Zeng, Z. (2023). Development of smart optical agents for disease theranostics. Doctoral thesis, Nanyang Technological University, Singapore. https://hdl.handle.net/10356/173441 https://hdl.handle.net/10356/173441 10.32657/10356/173441 en 2019-T1-002-045, RG125/19,RT05/20 NTUSUG: M4081627.120 This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License (CC BY-NC 4.0). application/pdf Nanyang Technological University
institution Nanyang Technological University
building NTU Library
continent Asia
country Singapore
Singapore
content_provider NTU Library
collection DR-NTU
language English
topic Engineering
spellingShingle Engineering
Zeng, Ziling
Development of smart optical agents for disease theranostics
description For the past decades, tremendous progress has been made in the field of biophotonics with applications in both biomedical research and clinical practice. With the merits of high sensitivity and specificity in real-time biological investigations and increased versatility and multimodality adaptive to diverse research and clinical needs, biophotonics as a powerful and non-invasive tool holds significant potential in disease treatment and diagnostics. Compared to inorganic optical agents, organic optical agents possess superiorities of high biocompatibility and biosafety, structurally tunable properties, and relatively low cost, rendering them attractive candidates for two major biomedical applications of biophotonics: 1) light-activated therapy; 2) optical imaging and diagnosis. Despite the fact that a diverse array of organic optical agents has been exploited in preclinical studies, there is still ample room for improvement and expanded clinical applications, such as lack in a precisely controllable manner, noninvasive, dynamic diagnosis of disease, or monitoring of disease progression. Therefore, our group has dedicated great efforts to overcoming these challenges, improving the performance of activatable optical agents, and expanding their use in various disease models and practical scenarios. This thesis is built with a structure of the following: a comprehensive review emphasizing past studies and current advances in biophotonics for disease treatment and diagnosis. Next, my studies that focused on improving optical agents from the aspects of precise control and extended clinical applications are presented. Specifically, to achieve the precise control of therapeutics, Chapter 3 investigates activatable organic semiconducting polymer nanoparticles (SPNs) for combination photodynamic immunotherapy, in which both photodynamic and immunotherapeutic activities can be controlled by photoirradiation. Based on Chapter 3, Chapter 4 further explores the SPNs as sonosensitizers for activatable sonoimmunotherpy, which overcomes the shallow tissue penetration of light, an inherent limitation of conventional phototherapy. To broaden the clinical applications and enhance the translational potential of activatable optical agents, Chapter 5 investigates a proof-of-concept approach to develop novel inhalable activatable probes, which enable both in vivo NIRF imaging and optical urinalysis allowing non-invasive and real-time detection of SARS-CoV-2. Inspired by this concept, Chapter 6 investigated the use of inhalable probes in longitudinal monitoring of disease progression and treatment outcomes. Finally, considering the rapid progression and great potential of smart optical agents, future perspectives from the aspects of optical agent development and clinical translation are proposed.
author2 Pu Kanyi
author_facet Pu Kanyi
Zeng, Ziling
format Thesis-Doctor of Philosophy
author Zeng, Ziling
author_sort Zeng, Ziling
title Development of smart optical agents for disease theranostics
title_short Development of smart optical agents for disease theranostics
title_full Development of smart optical agents for disease theranostics
title_fullStr Development of smart optical agents for disease theranostics
title_full_unstemmed Development of smart optical agents for disease theranostics
title_sort development of smart optical agents for disease theranostics
publisher Nanyang Technological University
publishDate 2024
url https://hdl.handle.net/10356/173441
_version_ 1794549354961305600